Jared Polis

More than half of U.S. states have enacted legislation requiring a certain percentage of renewable energy consumption by varying deadlines, a move scientists argue is unwise and not based on sound data.

A D.C.-based nonprofit group Power the Future is pressing Colorado Governor-Elect Jared Polis (D.) to rebuff environmental lobbying efforts calling on Polis enact a moratorium on all new oil and gas drilling in the state.

A female staffer for Jared Polis, the Democratic nominee for governor in Colorado, angrily confronted a conservative activist at a public political event and grabbed the activist’s phone out of his hand.

Shortly after being elected in 2008 to his first term in Congress, Jared Polis emailed Obama transition co-chair John Podesta to push his sister as a candidate for a presidentially appointed job with the incoming administration, according to hacked emails published online.

The Democratic nominee for governor in Colorado “pushed back hard” on a local television news report set to make a detailed examination of the candidate’s personal finances, especially as it pertains to statements he has made about transparency, and how great a decision-making role he might have had in some of his investments while serving in congress.

Jared Polis, the Democratic nominee for governor in Colorado, was involved in a physical altercation with an ex-employee in which he admitted to police he pushed the woman, according to a police report obtained by the Washington Free Beacon.

State Victory Action, a 527 political organization which has been funded primarily by billionaire activists George Soros and Tom Steyer, made a $500,000 donation to a group in Colorado which is supporting Representative Jared Polis, the Democratic nominee for governor.

Jared Polis, the Democrat nominee for governor of Colorado, is making prescription drug prices a campaign issue, but his congressional financial disclosures show he’s invested in numerous ETFs which held some of the world’s biggest pharmaceutical companies, such as Bristol-Myers Squibb, Merck, Phizer, Mylan, and Teva.